Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2325 of 2873 entries
View as:

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06274047 Org: User:
Start: 09/10/24 End: 06/30/29 Due: 06/30/30

Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03093909 Org: User:
Start: 11/22/17 End: 11/30/25 Due: 11/30/26

Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00929214 Org: User:
Start: 06/24/09 End: 12/01/25 Due: 12/01/26

Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03565783 Org: User:
Start: 07/03/18 End: 12/31/25 Due: 12/31/26

Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC)

Phase: N/A Priority: Normal
NCT ID: NCT01263769 Org: User:
Start: 02/28/11 End: 06/05/23 Due: 06/05/24

A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00519272 Org: User:
Start: 07/21/06 End: 05/15/19 Due: 05/15/20

Phase 1b/2 Study of Decitabine and Venetoclax in Combination With the Targeted Mutant IDH1 Inhibitor Olutasidenib

Phase: N/A Priority: Normal
NCT ID: NCT06445959 Org: User:
Start: 08/29/24 End: 06/30/29 Due: 06/30/30

Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02494700 Org: User:
Start: 07/06/15 End: 06/30/25 Due: 06/30/26

Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00446173 Org: User:
Start: 03/31/07 End: 01/31/09 Due: 01/31/10

Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00507923 Org: User:
Start: 11/07/06 End: 08/11/22 Due: 08/11/23

Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study

Phase: N/A Priority: Normal
NCT ID: NCT04978584 Org: User:
Start: 03/03/22 End: 01/16/27 Due: 01/16/28

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01266642 Org: User:
Start: 02/08/11 End: 11/30/25 Due: 11/30/26

Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01473628 Org: User:
Start: 05/20/13 End: 05/20/27 Due: 05/20/28

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03575611 Org: User:
Start: 06/14/18 End: 09/30/25 Due: 09/30/26

Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04132505 Org: User:
Start: 10/22/19 End: 12/31/26 Due: 12/31/27

Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02877303 Org: User:
Start: 11/01/16 End: 11/01/26 Due: 11/01/27

Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04171219 Org: User:
Start: 03/19/20 End: 03/11/25 Due: 03/11/26

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT00539500 Org: User:
Start: 10/31/07 End: 09/05/12 Due: 09/05/13

Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02420717 Org: User:
Start: 07/15/15 End: 01/20/21 Due: 01/20/22

Computer-Assisted Counseling in Helping African American Smokers Stop Smoking

Phase: N/A Priority: Normal
NCT ID: NCT00310141 Org: User:
Start: 04/08/02 End: 08/30/16 Due: 08/30/17

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

Phase: N/A Priority: Normal
NCT ID: NCT07010315 Org: User:
Start: 05/01/25 End: 04/30/27 Due: 04/30/28

Intrapleural Catheter Daily Versus Three Times a Week Drainage

Phase: N/A Priority: Normal
NCT ID: NCT00761618 Org: User:
Start: 08/22/08 End: 08/31/26 Due: 08/31/27

Testosterone Replacement for Fatigue in Male Hypogonadic Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00965341 Org: User:
Start: 09/30/09 End: 09/30/12 Due: 09/30/13

Pegasys in Patients With Chronic Myeloid Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT01392170 Org: User:
Start: 10/31/11 End: 03/31/14 Due: 03/31/15

Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT00566618 Org: User:
Start: 11/01/07 End: 11/17/20 Due: 11/17/21